|
|
 |
|
Viewing report
|
|
|
|
China HealthCare & Pricing System Reform 2008
Liang Kong, Oct 2008, Pages: 162
China represents one of the fastest growing pharmaceutical markets in the world and is the most lucrative market in Asia. Since 1978, the annual growth rate for China’s pharmaceutical market volume has increased by more than 15% every year. So no one can neglect the huge potential of China with its pharmaceutical market that is expanding greatly day by day.
China’s pharmaceutical pricing and reimbursement is a complex and ever-changing area. In a rapidly evolving market it is essential that executives are briefed on the regulatory systems that determine the way in which your company operates and sells its products. The pricing and reimbursement of prescription pharmaceuticals is a critically important issue for both the research-based and generic drug industry everywhere in the world where drug prices are not left to the forces of the free market and competition, definitely included China.
The Healthcare & pricing reform in China - Understanding the pharmaceutical market in the healthcare system is a straightforward guide to the pricing and reimbursement mechanisms in China market, in particular recent reforms since 2007 and the current proposed healthcare reform in the end of 2008.
The aim of this report is to add to the understanding of some of the mechanisms that have been adopted in Chinese markets, and to identify the major topics of interest and concern to health insurers, governments and the industry. The following are explained clearly in the report: how the healthcare system developed, the current state of healthcare in the country and the processes for negotiating drug reimbursement. The flaws in the system and a look at government attempts and industry pressure for reform were also detailed.
The 162 page report also clearly explains the structure of the healthcare system and the regulations and arrangements in place that provide the framework for setting medicine prices and gaining reimbursement in China.
Reasons to read this report:
- Stay up-to-date with the latest trends in China’s pharmaceutical pricing & reimbursement market
- Save time by concisely explaining the key elements of pricing and reimbursement regulation in China
- Understand the principles of China’s future healthcare reform & pricing reform
- Gain insight into the latest policies and the political environment affecting the reimbursement of medicines
- Increase your knowledge of the ways in which governments influence and control the pharmaceutical industry
- Forecast how governments will implement drug spending cost containment measures
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Pharmaceutical Pricing and Reimbursement in China
Pharmaceutical Market and Health Care Reform in China 2008
Pharmaceutical Pricing, Reimbursement Environment in China
Reform in China Electric Power Industry and Relevant Policies 2002
China's Railway Construction Market Report , 2006
China Life Insurance Market Report 2007
China Life Insurance Market Report, 2007
China Healthcare Sector Analysis
Executive Report on Strategies in China
Chinese Pharmaceutical Market Overview - Regulatory Reform and the Evolving Healthcare Market Provide Opportunities in China
The Challenges of Reference Pricing in Europe
China Coal Industry Report, 2007-2008
|
|
|
|
